The frustration of the two justices who wrote scathing dissents is easy to understand.
The Supreme Court ensured that the abortion pill, mifepristone, can continue to be available by mail without an in-person meeting with a clinician.
Louisiana had sued the FDA in a bid to curtail the regulatory agency’s rules on prescribing mifepristone remotelySign up for the Breaking News US newsletter emailThe US supreme court upheld nationwide access to mail-order mifepristone, an abortion medication, in a shadow-docket decision on Thursday.Louisiana sued the US Food and Drug Administration (FDA)…
A federal appeals court ruling against the Food and Drug Administration would have restricted access by mail to mifepristone.
The Supreme Court has maintained mail access to the abortion pill mifepristone, setting aside for now a lower court order that blocked abortion providers from prescribing the widely used drug through telehealth and shipping it to patients.
The US Supreme Court let a widely used abortion pill continue to be dispensed by mail, putting on hold a federal appeals court decision that had briefly required patients to make an in-person visit to a provider. Kailey Leinz and Joe Mathieu report on "Balance of Power: Evening Edition." (Source: Bloomberg)
On May 1, 2026, the Fifth Circuit Court of Appeals ruled to temporarily reinstate in-person dispensing requirements for the abortion pill mifepristone — blocking its delivery by mail or telemedicine nationwide.The ruling paused 2023 FDA regulations to allow remote prescribing and was immediately appealed to the Supreme Court.Dr. Christina Francis tells…
Dissent warns: 'It is a criminal offense to ship mifepristone for use in abortions'
The Supreme Court restored access on Thursday to mail-order abortion pills nationwide, lifting an appeals court’s block on a 2023 FDA rule which had removed the in-person requirement for mifepristone. In an unsigned order, the high court ruled 7-2 in favor of issuing a stay, which indefinitely pauses a May 1 ruling by the U.S.…
